Blackstone Inc
ACET icon

Blackstone Inc’s Adicet Bio ACET Stock Holding History

Blackstone Inc’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-77,278
Closed -$934K – 169
2025
Q1 		$934K Hold
77,278
– – ﹤0.01% 122
2024
Q4 		$1.19M Hold
77,278
– – 0.01% 123
2024
Q3 		$1.78M Hold
77,278
– – 0.01% 115
2024
Q2 		$1.5M Hold
77,278
– – 0.01% 125
2024
Q1 		$2.91M Buy
+77,278
New +$3.2M 0.01% 108

Other funds holding ACET

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return